M Suckfüll

Summary

Affiliation: University of Munich
Country: Germany

Publications

  1. ncbi A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitus
    Markus Suckfüll
    University of Munich, Department of Oto Rhino Laryngolgy, Marchioninistrase 15, 81377 Munich, Germany
    BMC Ear Nose Throat Disord 11:1. 2011
  2. ncbi Perspectives on the pathophysiology and treatment of sudden idiopathic sensorineural hearing loss
    Markus Suckfüll
    Klinikum der Universitat Munchen, Klinik und Poliklinik Fur Hals, Nasen und Ohrenheilkunde
    Dtsch Arztebl Int 106:669-75; quiz 676. 2009
  3. ncbi Intratympanic treatment of acute acoustic trauma with a cell-permeable JNK ligand: a prospective randomized phase I/II study
    M Suckfuell
    Ludwig Maximilians Universitat Munchen, Munchen, Germany
    Acta Otolaryngol 127:938-42. 2007
  4. ncbi [Up to date: therapy of sudden hearing loss]
    M Suckfüll
    Klinik für Hals Nasen Ohren Heilkunde der Ludwig Maximilians Universität München
    Laryngorhinootologie 84:277-82; quiz 283-87. 2005
  5. ncbi [Acute diseases of the inner ear--are cardiovascular treatment strategies lacking?]
    M Suckfüll
    Klinikum Innenstadt der LMU München
    MMW Fortschr Med 146:52-5. 2004
  6. ncbi [Treatment of sudden hearing loss through Fibrinogen/LDL-apheresis. A prospective, randomized multicenter trial]
    M Suckfüll
    Klinik für Hals Nasen Ohrenheilkunde der Ludwig Maximilians Universität München, Klinikum Grosshadern, Marchioninistrasse 15, 81377 Munchen, Germany
    Z Kardiol 92:III59-63. 2003
  7. ncbi [Cochlear and vestibular risk at high altitude]
    K Mees
    Klinik und Poliklinik Fur Hals, Nasen und Ohrenkranke, Ludwig Maximilians Universitat Munchen
    Laryngorhinootologie 81:465-8. 2002
  8. ncbi Heparin-Induced extracorporeal low-density lipoprotein precipitation apheresis: a new therapeutic concept in the treatment of sudden hearing loss
    M Suckfüll
    Department of Otorhinolaryngology, Head and Neck Surgery, Ludwig Maximilians University Munich, Germany
    Ther Apher 5:377-83. 2001
  9. ncbi [An unusual case of carotid arrosion bleeding]
    P Zengel
    Klinik und Poliklinik für Hals Nasen Ohren Heilkunde, Klinikum Grosshadern, Ludwig Maximilians Universitat, 81377 Munchen
    HNO 57:1203-8. 2009
  10. ncbi Clinical utility of LDL-apheresis in the treatment of sudden hearing loss: a prospective, randomized study
    M Suckfüll
    Department of Otorhinolarnygology, Head and Neck Surgery, Ludwig Maximilians University Munich, University Hospital Grosshadern, Germany
    Acta Otolaryngol 119:763-6. 1999

Detail Information

Publications14

  1. ncbi A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitus
    Markus Suckfüll
    University of Munich, Department of Oto Rhino Laryngolgy, Marchioninistrase 15, 81377 Munich, Germany
    BMC Ear Nose Throat Disord 11:1. 2011
    ..abstract:..
  2. ncbi Perspectives on the pathophysiology and treatment of sudden idiopathic sensorineural hearing loss
    Markus Suckfüll
    Klinikum der Universitat Munchen, Klinik und Poliklinik Fur Hals, Nasen und Ohrenheilkunde
    Dtsch Arztebl Int 106:669-75; quiz 676. 2009
    ..Sudden, idiopathic sensorineural hearing loss is an acute dysfunction of the inner ear whose cause cannot be determined with the currently available methods of clinical diagnosis...
  3. ncbi Intratympanic treatment of acute acoustic trauma with a cell-permeable JNK ligand: a prospective randomized phase I/II study
    M Suckfuell
    Ludwig Maximilians Universitat Munchen, Munchen, Germany
    Acta Otolaryngol 127:938-42. 2007
    ..Intratympanic administration of a cell-permeable JNK ligand has been shown to prevent hearing loss after acute acoustic trauma in animal models...
  4. ncbi [Up to date: therapy of sudden hearing loss]
    M Suckfüll
    Klinik für Hals Nasen Ohren Heilkunde der Ludwig Maximilians Universität München
    Laryngorhinootologie 84:277-82; quiz 283-87. 2005
    ..Following is a description of five different forms of sudden hearing loss, its suspected pathogenesis and different therapeutic strategies recommended for the treatment of sudden hearing loss...
  5. ncbi [Acute diseases of the inner ear--are cardiovascular treatment strategies lacking?]
    M Suckfüll
    Klinikum Innenstadt der LMU München
    MMW Fortschr Med 146:52-5. 2004
    ..Here there is a promising and wide field of options for such diseases that can be traced back to regional perfusion disorders...
  6. ncbi [Treatment of sudden hearing loss through Fibrinogen/LDL-apheresis. A prospective, randomized multicenter trial]
    M Suckfüll
    Klinik für Hals Nasen Ohrenheilkunde der Ludwig Maximilians Universität München, Klinikum Grosshadern, Marchioninistrasse 15, 81377 Munchen, Germany
    Z Kardiol 92:III59-63. 2003
    ..Acute reduction of plasma fibrinogen and serum LDL positively influences hemorheology and endothelial function and might thus be an effective therapy for SSHL...
  7. ncbi [Cochlear and vestibular risk at high altitude]
    K Mees
    Klinik und Poliklinik Fur Hals, Nasen und Ohrenkranke, Ludwig Maximilians Universitat Munchen
    Laryngorhinootologie 81:465-8. 2002
    ..Even an greater increase in serum osmolality or an impaired osmoregulation may not interfere with the outer hair cell function resulting in threshold shift and hearing loss...
  8. ncbi Heparin-Induced extracorporeal low-density lipoprotein precipitation apheresis: a new therapeutic concept in the treatment of sudden hearing loss
    M Suckfüll
    Department of Otorhinolaryngology, Head and Neck Surgery, Ludwig Maximilians University Munich, Germany
    Ther Apher 5:377-83. 2001
    ..The clinical impression and first controlled data make it likely that HELP apheresis is useful in the therapy of sudden hearing loss with suspected vascular origin...
  9. ncbi [An unusual case of carotid arrosion bleeding]
    P Zengel
    Klinik und Poliklinik für Hals Nasen Ohren Heilkunde, Klinikum Grosshadern, Ludwig Maximilians Universitat, 81377 Munchen
    HNO 57:1203-8. 2009
    ..The tip was removed, the defect closed and covered with a pectoralis major muscle flap...
  10. ncbi Clinical utility of LDL-apheresis in the treatment of sudden hearing loss: a prospective, randomized study
    M Suckfüll
    Department of Otorhinolarnygology, Head and Neck Surgery, Ludwig Maximilians University Munich, University Hospital Grosshadern, Germany
    Acta Otolaryngol 119:763-6. 1999
    ..Re-establishment of vascular endothelial function and improved blood rheology may be the underlying cause. These results must be confirmed in larger-scale trials...
  11. ncbi Changes in serum osmolarity influence the function of outer hair cells
    M Suckfüll
    Department of Otorhinolaryngology, Head and Neck Surgery, University of Munich, Germany
    Acta Otolaryngol 119:316-21. 1999
    ..In patients suffering from sudden hearing loss. dehydration due to physical or mental stress is often observed. This new and promising pathophysiological concept needs further clinical evaluation...
  12. ncbi Subpixel tracking for the analysis of outer hair cell movements
    M Canis
    Department of Otorhinolaryngology, Head and Neck Surgery, University of Munich, Germany
    Acta Otolaryngol 128:228-32. 2008
    ..Videomicroscopy with subpixel analysis is an excellent system for quantification of outer hair cell (OHC) movements. The resolution of a few nanometers is accurate enough to show induced differences of electromotility...
  13. ncbi [Fibrinogen/LDL apheresis for treatment of sudden hearing loss: an observational study on 152 patients]
    M Canis
    Klinik und Poliklinik für Hals Nasen Ohren Heilkunde der Ludwig Maximilians Universität, Klinikum Grosshadern, Machioninistrasse 15, 81377, Munchen, Deutschland
    HNO 56:961-6. 2008
    ..The present study shows that apheresis achieved complete or partial remission in 54% of patients even after unsuccessful treatment with another therapy and the therapeutic window lies by approximately 6 weeks...
  14. ncbi Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial
    M Suckfüll
    Klinikum Grosshadern, 81377, Munchen, Germany
    Lancet 360:1811-7. 2002
    ..We aimed to determine whether acute reduction of plasma fibrinogen and serum LDL is effective for treatment of SSHL of suspected vascular origin...